3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone
97%
- Product Code: 75370
CAS:
898762-43-1
Molecular Weight: | 391.39 g./mol | Molecular Formula: | C₂₁H₂₀F₃NO₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD03842223 | |
Melting Point: | Boiling Point: | 508℃ at 760 mmHg | |
Density: | 1.35g/ml | Storage Condition: | Room temperature, sealed, ventilated |
Product Description:
This compound is primarily utilized in the field of organic synthesis, particularly as an intermediate in the development of more complex chemical structures. Its unique molecular framework, which includes a trifluorobenzophenone moiety and a dioxa-azaspiro component, makes it valuable for constructing pharmacologically active molecules. Researchers often employ it in the synthesis of potential drug candidates, especially those targeting neurological or psychiatric disorders, due to its ability to interact with specific biological receptors. Additionally, its structural features allow for further functionalization, enabling the creation of diverse chemical libraries for high-throughput screening in drug discovery programs.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | £1,271.98 |
+
-
|
2.000 | 10-20 days | £2,112.88 |
+
-
|
3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone
This compound is primarily utilized in the field of organic synthesis, particularly as an intermediate in the development of more complex chemical structures. Its unique molecular framework, which includes a trifluorobenzophenone moiety and a dioxa-azaspiro component, makes it valuable for constructing pharmacologically active molecules. Researchers often employ it in the synthesis of potential drug candidates, especially those targeting neurological or psychiatric disorders, due to its ability to interact with specific biological receptors. Additionally, its structural features allow for further functionalization, enabling the creation of diverse chemical libraries for high-throughput screening in drug discovery programs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :